Keyphrases
Compound muscle Action Potential
47%
Chronic Inflammatory Demyelinating Polyneuropathy
47%
Acute Inflammatory Demyelinating Polyneuropathy
25%
Axial muscles
23%
Diagnostic Parameters
23%
Autonomic Dysfunction
23%
Peripheral Nervous System Involvement
23%
Neuromuscular Manifestations
23%
Dementia with Lewy Bodies
23%
Demyelinating Neuropathy
23%
Paraneoplastic Neuropathy
23%
Muromonab-CD3
23%
Lyme Borreliosis
23%
Electrodiagnosis
23%
Virtual Obstacles
23%
Autonomic Nervous System
23%
MANOS
23%
Neuromuscular Complications
23%
Bariatric Surgery Complications
23%
American Academy of Neurology
23%
Nutritional Control
23%
Lumbosacral Radiculoplexus Neuropathy
23%
Vasculitic Neuropathy
23%
Consensus Statement
23%
Cryptogenic Sensory Polyneuropathy
23%
International Federations
23%
Pure Autonomic Failure
23%
Small Fiber Neuropathy
23%
Diagnostic Criteria
23%
Facioscapulohumeral muscular Dystrophy
23%
Becker muscular Dystrophy
23%
Adaptive Platform Trial
23%
Quantitative Sudomotor Axon Reflex Test
23%
Acid Maltase Deficiency
23%
Clinical Neurophysiology
23%
Lumbosacral Plexopathy
23%
Distal Compound muscle Action Potential Duration
19%
Radicular Pain
15%
Cerebrospinal Fluid Infection
15%
Radiculoneuropathy
15%
Chronic Lyme
15%
Lyme
15%
Facial Palsy
15%
Composite Autonomic Scoring Scale
14%
Sensory Polyneuropathy
14%
Electrodiagnostic Criteria
12%
Multiple System Atrophy
11%
Early Diagnosis
11%
Organ Involvement
11%
Primary Systemic Amyloidosis
11%
Medicine and Dentistry
Neuropathy
70%
Plexopathy
47%
Amyotrophic Lateral Sclerosis
47%
Weakness
39%
Symptom
35%
Electrodiagnosis
29%
Disease
24%
Rasagiline
23%
Randomized Controlled Trial
23%
Glucan 1,4 Alpha Glucosidase
23%
Compound Muscle Action Potential
23%
Chronic Inflammatory Demyelinating Polyneuropathy
23%
Peripheral Nervous System
23%
Minocycline
23%
OKT 3
23%
Salicylate Sodium
23%
Demyelinating Neuropathy
23%
Electromyography
23%
Autonomic Nervous System
23%
Bariatric Surgery
23%
Dietary Intake
23%
Clinical Neurophysiology
23%
Small Fiber Neuropathy
23%
Neurology
23%
Primary Lateral Sclerosis
23%
Respiratory Failure
23%
Becker Muscular Dystrophy
23%
Immunotherapy
22%
Polyradiculoneuropathy
21%
Vasculitis
19%
Lumbosacral Plexus
17%
Necrotizing Arteritis
17%
Mexiletine
16%
Muscle Biopsy
15%
Peripheral Nerve
15%
Pathophysiology
13%
Placebo
13%
Physical Disease by Body Function
11%
Radicular Pain
11%
Early Diagnosis
11%
Amyloidosis
11%
Clinical Examination
11%
Paresthesia
11%
Ischemic Injury
10%
Mononeuropathy
10%
Acneiform Eruption
9%
Nicotinamide Adenine Dinucleotide
8%
Forced Vital Capacity
8%
Rating Scale
8%
Polyneuropathy
8%
Neuroscience
Peripheral Neuropathy
100%
Polyneuropathy
70%
Diabetic Neuropathy
60%
Amyotrophic Lateral Sclerosis
54%
Action Potential
47%
Immunotherapy
41%
Dysautonomia
39%
Electrodiagnosis
38%
Dementia with Lewy Bodies
35%
Diabetes Mellitus
35%
Lumbosacral Plexus
35%
Quantitative Sensory Testing
27%
Glucan 1,4 Alpha Glucosidase
23%
Carpal Tunnel Syndrome
23%
Peripheral Nerve
23%
Brachial Plexus
23%
Lewy Body
23%
Parkinson's Disease
23%
Multiple System Atrophy
23%
Peripheral Nervous System
23%
Muromonab-CD3
23%
Somatics
23%
Randomized Controlled Trial
23%
Nerve Fiber
23%
Primary Lateral Sclerosis
23%
Clinical Neurophysiology
23%
Rasagiline
23%
Axon
18%
Mexiletine
16%
Placebo
13%
Amyloidosis
11%
Synuclein
11%
Autonomic Ganglion
11%
Nerve Cell Degeneration
11%
Cross Reacting Antibody
7%
Pain Threshold
7%
